XML 135 R108.htm IDEA: XBRL DOCUMENT v3.23.3
Segment reporting - results of operations of reportable segments (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Aug. 31, 2023
May 31, 2023
Feb. 28, 2023
Nov. 30, 2022
Aug. 31, 2022
May 31, 2022
Feb. 28, 2022
Nov. 30, 2021
Aug. 31, 2023
Aug. 31, 2022
Aug. 31, 2021
Segment Reporting Information, Operating Income (Loss) [Abstract]                      
Sales $ 35,422 $ 35,415 $ 34,862 $ 33,382 $ 32,449 $ 32,597 $ 33,756 $ 33,901 $ 139,081 $ 132,703 $ 132,509
Adjusted operating income                 3,871 5,133 5,117
Depreciation and amortization                 2,257 1,990 1,923
Capital expenditures                 2,117 1,734 1,312
Certain legal and regulatory accruals and settlements                 (7,466) (768) (75)
Transformational cost management                 (1,181) (763) (417)
Acquisition-related amortization                 (1,126) (855) (523)
Acquisition-related costs                 (323) (223) (54)
Impairment of intangible assets                 (299) (783) (49)
Adjustments to equity earnings in Cencora                 (211) (218) (1,645)
LIFO provision                 (187) (135) (13)
Store damage and inventory loss insurance recovery                 40 0 0
Operating (loss) income                 (6,882) 1,387 2,342
Reportable Segments | U.S. Retail Pharmacy                      
Segment Reporting Information, Operating Income (Loss) [Abstract]                      
Sales                 110,314 109,078 112,005
Adjusted operating income                 3,689 5,029 5,019
Depreciation and amortization                 1,362 1,415 1,513
Capital expenditures                 1,421 1,207 1,030
Reportable Segments | International                      
Segment Reporting Information, Operating Income (Loss) [Abstract]                      
Sales                 22,198 21,830 20,505
Adjusted operating income                 935 726 466
Depreciation and amortization                 328 355 399
Capital expenditures                 308 295 243
Reportable Segments | U.S. Healthcare                      
Segment Reporting Information, Operating Income (Loss) [Abstract]                      
Sales                 6,570 1,795 0
Adjusted operating income                 (566) (370) (57)
Depreciation and amortization                 560 211 1
Capital expenditures                 375 218 34
Corporate and Other                      
Segment Reporting Information, Operating Income (Loss) [Abstract]                      
Adjusted operating income                 (187) (251) (311)
Depreciation and amortization                 8 9 10
Capital expenditures                 $ 13 $ 15 $ 5